医学
经导管动脉化疗栓塞
放射科
肝细胞癌
栓塞
内科学
阿霉素
丙氨酸转氨酶
碘化油
白蛋白
外科
选择性内照射治疗
回顾性队列研究
性能状态
中性粒细胞与淋巴细胞比率
实体瘤疗效评价标准
作者
Won-Du Chang,Myoung Soo Kim
标识
DOI:10.1097/cin.0000000000001414
摘要
Although there is no framework for prediction models for postembolization fever, potential influencing factors include demographic, clinical, laboratory, and radiologic data. We aim to develop and validate machine learning-based prediction models for postembolization fever after transarterial chemoembolization. Data from 1495 patients who underwent transarterial chemoembolization at a tertiary hospital were reviewed retrospectively. Seven machine learning-based algorithms were used to develop prediction models of postembolization fever occurrence after transarterial chemoembolization using SPSS WIN 27.0 and Python. The proposed ensemble method was the best algorithm for predicting postembolization fever. Variables positively correlated with postembolization fever occurrence were posttransarterial chemoembolization aspartate aminotransferase, C-reactive protein, alanine aminotransferase, and bilirubin levels, and international normalized ratio and platelet counts; pretransarterial chemoembolization aspartate aminotransferase and alpha-fetoprotein levels and platelet count; lipiodol and doxorubicin amounts; and a >5 cm tumor. Conversely, variables negatively correlated with postembolization fever were posttransarterial chemoembolization lymphocyte and monocyte counts and albumin levels; pretransarterial chemoembolization albumin levels and lymphocyte count; and probably hepatocellular carcinoma. Oncology clinicians should monitor demographic, clinical, laboratory, and radiologic data before and after transarterial chemoembolization to assess postembolization fever. In addition, health care professionals should be aware of the potential side effects of transarterial chemoembolization and management strategies, such as medications.
科研通智能强力驱动
Strongly Powered by AbleSci AI